{"id":"placebo-acetazolamide","safety":{"commonSideEffects":[{"rate":null,"effect":"Paresthesia"},{"rate":null,"effect":"Altered taste"},{"rate":null,"effect":"Increased urination"},{"rate":null,"effect":"Hypokalemia"},{"rate":null,"effect":"Metabolic acidosis"}]},"_chembl":{"chemblId":"CHEMBL20","moleculeType":"Small molecule","molecularWeight":"222.25"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo-acetazolamide","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T06:16:38.600236+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T06:16:45.724348+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo-acetazolamide","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T06:16:46.427547+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Carbonic anhydrase IV inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:16:46.994767+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL20/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:16:46.896309+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Acetazolamide is a carbonic anhydrase inhibitor that decreases aqueous humor secretion in the eye, thereby lowering intraocular pressure. The 'placebo-acetazolamide' designation suggests this is a formulation or study design combining active drug with placebo control, likely used in comparative clinical trials. This combination approach allows for assessment of acetazolamide's true efficacy against placebo baseline.","oneSentence":"Acetazolamide inhibits carbonic anhydrase to reduce aqueous humor production and intraocular pressure, while the placebo component serves as a control in clinical evaluation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:00:33.870Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:16:48.730535+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Glaucoma and ocular hypertension"}]},"trialDetails":[{"nctId":"NCT04118387","phase":"PHASE4","title":"Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-01-07","conditions":"Sleep Disordered Breathing, Able Bodied","enrollment":200},{"nctId":"NCT06043830","phase":"PHASE2","title":"Managing Opioid Related Sleep Apnea With Acetazolamide","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2023-10-18","conditions":"Sleep-Disordered Breathing, Obstructive Sleep Apnea, Central Sleep Apnea","enrollment":39},{"nctId":"NCT07101250","phase":"PHASE4","title":"Preoperative Acetazolamide","status":"RECRUITING","sponsor":"Prisma Health-Upstate","startDate":"2025-10-30","conditions":"Post Operative Pain, Laparoscopic Hysterectomy, Referred Pain","enrollment":100},{"nctId":"NCT06499727","phase":"PHASE4","title":"HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to Men","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2024-07-15","conditions":"Acute Mountain Sickness","enrollment":303},{"nctId":"NCT05589792","phase":"PHASE1, PHASE2","title":"Acetazolamide on REM OSA","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2023-01-30","conditions":"Obstructive Sleep Apnea","enrollment":11},{"nctId":"NCT05616260","phase":"PHASE2","title":"Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2022-12-02","conditions":"Obstructive Sleep Apnea","enrollment":54},{"nctId":"NCT06521476","phase":"PHASE2","title":"Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder","status":"RECRUITING","sponsor":"Sanjay R Patel","startDate":"2025-09-30","conditions":"Central Sleep Apnea Comorbid With Opioid Use","enrollment":40},{"nctId":"NCT06776432","phase":"PHASE2","title":"Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea","status":"RECRUITING","sponsor":"Shionogi Apnimed Sleep Science","startDate":"2025-04-02","conditions":"Sleep Apnea","enrollment":60},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT04726982","phase":"PHASE4","title":"Optimal Dosage of Acetazolamide for OSA Treatment","status":"COMPLETED","sponsor":"University Hospital, Antwerp","startDate":"2021-04-20","conditions":"Obstructive Sleep Apnea","enrollment":91},{"nctId":"NCT02703220","phase":"PHASE4","title":"Sleep Apnea in Elderly","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2015-07-03","conditions":"Sleep Apnea, Elderly Adults","enrollment":100},{"nctId":"NCT07118462","phase":"PHASE4","title":"HighCycle Study: Acetazolamide, High Altitude and Plasma Volume","status":"RECRUITING","sponsor":"Centre d'Expertise sur l'Altitude EXALT","startDate":"2024-07-15","conditions":"High Altitude Effects, High Altitude Hypoxia, Acute Mountain Sickness (AMS)","enrollment":270},{"nctId":"NCT04251364","phase":"NA","title":"Treatment of Chronic Mountain Sickness","status":"COMPLETED","sponsor":"Centre d'Expertise sur l'Altitude EXALT","startDate":"2020-02-15","conditions":"Hypoxia, Altitude","enrollment":60},{"nctId":"NCT05589753","phase":"PHASE1, PHASE2","title":"Sleep Disordered Breathing With Opioid Use","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-05-02","conditions":"Sleep Apnea, Opioid Use, Sleep Disordered Breathing","enrollment":150},{"nctId":"NCT06981234","phase":"PHASE2","title":"Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-08-14","conditions":"Type 1 Diabetes","enrollment":25},{"nctId":"NCT06498505","phase":"PHASE4","title":"HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2024-07-15","conditions":"High Altitude","enrollment":270},{"nctId":"NCT06498531","phase":"PHASE4","title":"HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2024-07-15","conditions":"Sleep-Disordered Breathing","enrollment":270},{"nctId":"NCT06146101","phase":"PHASE2, PHASE3","title":"RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incannex Healthcare Ltd","startDate":"2024-05-02","conditions":"Obstructive Sleep Apnea","enrollment":560},{"nctId":"NCT04887792","phase":"PHASE1, PHASE2","title":"Acetazolamide for Treatment Resistant Schizophrenia","status":"RECRUITING","sponsor":"Vishwajit Nimgaonkar, MD PhD","startDate":"2022-02-01","conditions":"Schizophrenia, Schizo Affective Disorder","enrollment":60},{"nctId":"NCT04975269","phase":"PHASE2","title":"Acetazolamide Trial in Normal Pressure Hydrocephalus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Uppsala University Hospital","startDate":"2022-02-17","conditions":"Idiopathic Normal Pressure Hydrocephalus (INPH)","enrollment":50},{"nctId":"NCT04679389","phase":"PHASE2, PHASE3","title":"Acetazolamide Efficacy in Ataxia in PMM2-CDG","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2021-03-17","conditions":"Pmm2-CDG, CDG1A","enrollment":25},{"nctId":"NCT06166654","phase":"PHASE4","title":"Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload","status":"RECRUITING","sponsor":"Johannes Grand","startDate":"2024-09-05","conditions":"Acute Heart Failure","enrollment":939},{"nctId":"NCT05804084","phase":"PHASE2","title":"Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2023-05-16","conditions":"Obstructive Sleep Apnea","enrollment":60},{"nctId":"NCT03505788","phase":"PHASE4","title":"Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2018-11-11","conditions":"Acute Decompensated Heart Failure, Volume Overload","enrollment":519},{"nctId":"NCT06475105","phase":"PHASE4","title":"Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes","status":"RECRUITING","sponsor":"Universitas Diponegoro","startDate":"2024-04-20","conditions":"Acute Decompensated Heart Failure","enrollment":66},{"nctId":"NCT04227093","phase":"PHASE4","title":"Acetazolamide Add-On Therapy to OSA Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2020-01-22","conditions":"Obstructive Sleep Apnea","enrollment":26},{"nctId":"NCT05293600","phase":"PHASE1, PHASE2","title":"Rescue Pharmacotherapy for OSA","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-07-01","conditions":"Obstructive Sleep Apnea","enrollment":70},{"nctId":"NCT04639193","phase":"PHASE2","title":"Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2020-12-01","conditions":"OSA, Obstructive Sleep Apnea","enrollment":20},{"nctId":"NCT06110078","phase":"EARLY_PHASE1","title":"Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda Consumption","status":"ENROLLING_BY_INVITATION","sponsor":"University of Arizona","startDate":"2024-01-18","conditions":"Obesity","enrollment":44},{"nctId":"NCT05575180","phase":"PHASE4","title":"Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance","status":"COMPLETED","sponsor":"University of Waterloo","startDate":"2023-08-11","conditions":"High Altitude Effects","enrollment":15},{"nctId":"NCT06091085","phase":"PHASE1, PHASE2","title":"Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-01-31","conditions":"OSA","enrollment":36},{"nctId":"NCT05940220","phase":"PHASE3","title":"Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2023-12-30","conditions":"Heart Failure","enrollment":130},{"nctId":"NCT02466074","phase":"PHASE2","title":"Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2016-08-17","conditions":"Multiple Sclerosis","enrollment":5},{"nctId":"NCT03540914","phase":"PHASE4","title":"Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude.","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2018-06-01","conditions":"Altitude Hypoxia","enrollment":400},{"nctId":"NCT04913389","phase":"PHASE3","title":"Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2021-06-01","conditions":"Chronic Obstructive Pulmonary Disease, Altitude Sickness, Altitude Hypoxia","enrollment":100},{"nctId":"NCT03537924","phase":"PHASE4","title":"Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at Altitude","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2018-06-01","conditions":"Altitude Hypoxia","enrollment":100},{"nctId":"NCT03539367","phase":"PHASE4","title":"Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2018-06-01","conditions":"Altitude Hypoxia","enrollment":100},{"nctId":"NCT04915365","phase":"PHASE3","title":"Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2021-05-01","conditions":"Right Heart Function, Chronic Obstructive Pulmonary Disease, Altitude Sickness","enrollment":100},{"nctId":"NCT04470843","phase":"PHASE1","title":"Impact of Acetazolamide in Reducing Referred Postoperative Pain","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2018-08-22","conditions":"Prostate Cancer, Men","enrollment":33},{"nctId":"NCT03536507","phase":"PHASE4","title":"Effect of Acetazolamide on Sleep Disordered Breathing in Lowlanders Older Than 40 Years at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-05-15","conditions":"Altitude Hypoxia","enrollment":185},{"nctId":"NCT03540901","phase":"PHASE4","title":"Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-05-22","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":112},{"nctId":"NCT03536429","phase":"PHASE4","title":"Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-05-15","conditions":"Altitude Hypoxia","enrollment":99},{"nctId":"NCT03177811","phase":"PHASE4","title":"Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-05-24","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":127},{"nctId":"NCT03536520","phase":"PHASE4","title":"Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-05-15","conditions":"Altitude Hypoxia","enrollment":59},{"nctId":"NCT03536455","phase":"PHASE4","title":"Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-05-15","conditions":"Altitude Hypoxia","enrollment":92},{"nctId":"NCT03561675","phase":"PHASE4","title":"Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-05-15","conditions":"Acute Mountain Sickness","enrollment":349},{"nctId":"NCT02755298","phase":"PHASE2, PHASE3","title":"Chronic Clinical Effect of Acetazolamide","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2016-10","conditions":"Hypertension, Pulmonary","enrollment":24},{"nctId":"NCT03177837","phase":"PHASE4","title":"Effect of Acetazolamide on Exercise Performance in Patients With Respiratory Disease at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-05-24","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":176},{"nctId":"NCT03173508","phase":"PHASE4","title":"Effect of Acetazolamide on Right Ventricular Function at Rest in Patients With Respiratory Disease at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-05-24","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":110},{"nctId":"NCT03167034","phase":"PHASE4","title":"Effect of Acetazolamide on Right Ventricular Function During Exercise in Patients With Respiratory Disease at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-05-24","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":110},{"nctId":"NCT02755259","phase":"PHASE2, PHASE3","title":"Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-01-01","conditions":"Hypertension, Pulmonary","enrollment":33},{"nctId":"NCT03525561","phase":"EARLY_PHASE1","title":"Acetazolamide and Exercise Performance at Altitude","status":"COMPLETED","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2018-10-10","conditions":"Hypoxia, Exercise Performance, Cognitive Function","enrollment":10},{"nctId":"NCT01973335","phase":"PHASE4","title":"Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure","status":"COMPLETED","sponsor":"Hasselt University","startDate":"2013-11","conditions":"Heart Failure","enrollment":34},{"nctId":"NCT03165890","phase":"PHASE4","title":"Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-05-24","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":78},{"nctId":"NCT03490916","phase":"PHASE4","title":"Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography","status":"TERMINATED","sponsor":"Vincent Kan","startDate":"2018-03-23","conditions":"High Altitude Pulmonary Edema","enrollment":18},{"nctId":"NCT03156231","phase":"PHASE4","title":"Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-05-24","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":185},{"nctId":"NCT03177850","phase":"PHASE4","title":"Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2017-05-24","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":185},{"nctId":"NCT02992938","phase":"PHASE4","title":"Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia","status":"COMPLETED","sponsor":"University of Chile","startDate":"2016-12","conditions":"Hyperalgesia, Opioid-Related Disorders","enrollment":50},{"nctId":"NCT02604173","phase":"PHASE3","title":"Altitude Sickness Prevention and Efficacy of Comparative Treatments","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-08","conditions":"Acute Mountain Sickness","enrollment":103},{"nctId":"NCT01003639","phase":"PHASE2, PHASE3","title":"Idiopathic Intracranial Hypertension Treatment Trial","status":"COMPLETED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2010-01","conditions":"Idiopathic Intracranial Hypertension","enrollment":165},{"nctId":"NCT03720288","phase":"PHASE3","title":"Acetazolamide in Patients With Acute Heart Failure","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2018-10-01","conditions":"Heart Failure, Acute Heart Failure","enrollment":90},{"nctId":"NCT02758470","phase":"PHASE4","title":"Muscle Fatigue and Carbonic Anhydrase Inhibitors","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2016-11","conditions":"Hypoxia","enrollment":13},{"nctId":"NCT01377987","phase":"NA","title":"Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients","status":"COMPLETED","sponsor":"David Andrew Wellman","startDate":"2011-08","conditions":"Heart Failures","enrollment":29},{"nctId":"NCT02371473","phase":"PHASE4","title":"Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2014-11","conditions":"Central Sleep Apnea, Secondary","enrollment":12},{"nctId":"NCT02163330","phase":"PHASE3","title":"Normal Pressure Hydrocephalus Treatment by Acetazolamide","status":"TERMINATED","sponsor":"Rabin Medical Center","startDate":"2014-06","conditions":"Motor Condition as Measured by Quantified Scale, Cognitive Investigation","enrollment":2},{"nctId":"NCT03107429","phase":"NA","title":"Effect of Acetazolamide on Intraocular Pressure After Being in the Trendelenburg Position.","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2015-03-01","conditions":"IOP","enrollment":9},{"nctId":"NCT00223691","phase":"PHASE1","title":"Treatment of Orthostatic Hypotension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2002-03","conditions":"Autonomic Failure, Orthostatic Hypotension","enrollment":389},{"nctId":"NCT02760121","phase":"PHASE4","title":"AZ, MZ, and the Pulmonary System Response to Hypoxia","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2016-05","conditions":"Altitude Sickness, Hypertension, Pulmonary","enrollment":14},{"nctId":"NCT00746954","phase":"PHASE3","title":"Buspirone as a Potential Treatment for Recurrent Central Apnea","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2008-09","conditions":"Central Apnea, Heart Failure","enrollment":8},{"nctId":"NCT01627639","phase":"PHASE4","title":"Effectiveness of Acetazolamide for Reversal of Metabolic Alkalosis in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-10","conditions":"Decompensated Chronic Obstructive Pulmonary Disease","enrollment":380},{"nctId":"NCT01187108","phase":"PHASE1, PHASE2","title":"Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2013-06","conditions":"Erythrocytosis, Mountain Sickness","enrollment":85},{"nctId":"NCT01499485","phase":"PHASE3","title":"Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.","status":"COMPLETED","sponsor":"Hospital Son Llatzer","startDate":"2011-11","conditions":"Pulmonary Disease, Chronic Obstructive, Obesity Hypoventilation Syndrome, Metabolic Alkalosis","enrollment":140},{"nctId":"NCT00928655","phase":"PHASE4","title":"Continuous Positive Airway Pressure and Acetazolamide to Treat Sleep Apnea Syndrome Patients at Altitude","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2009-06","conditions":"Obstructive Sleep Apnea Syndrome","enrollment":51},{"nctId":"NCT02140450","phase":"NA","title":"Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection","status":"COMPLETED","sponsor":"Mashhad University of Medical Sciences","startDate":"2012-02","conditions":"Intraocular Pressure Change in Intravitreal Injection","enrollment":70},{"nctId":"NCT00780325","phase":"PHASE1","title":"Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2008-10","conditions":"Healthy Volunteers","enrollment":26},{"nctId":"NCT00222534","phase":"PHASE4","title":"Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis","status":"COMPLETED","sponsor":"University of Oslo School of Pharmacy","startDate":"2002-01","conditions":"Respiratory Insufficiency, Alkalosis","enrollment":70},{"nctId":"NCT01418157","phase":"PHASE4","title":"A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2011-08","conditions":"Acute Mountain Sickness","enrollment":380},{"nctId":"NCT01427192","phase":"PHASE2","title":"Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2010-11","conditions":"Pulmonary Hypertension, Breathing-Related Sleep Disorder","enrollment":23},{"nctId":"NCT01682551","phase":"PHASE2","title":"Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness","status":"UNKNOWN","sponsor":"China Medical University Hospital","startDate":"2012-09","conditions":"Acute Mountain Sickness (AMS)","enrollment":240},{"nctId":"NCT01288781","phase":"NA","title":"Intracranial Pressure in Experimental Models of Headache","status":"COMPLETED","sponsor":"Bangor University","startDate":"2011-07","conditions":"High Altitude Headache","enrollment":23},{"nctId":"NCT00839501","phase":"PHASE1","title":"Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2008-12","conditions":"Andersen-Tawil Syndrome","enrollment":3},{"nctId":"NCT01131377","phase":"NA","title":"Acetazolamide Facilitates Ventilator Weaning","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2010-05","conditions":"Ventilator Weaning, Alkalosis, Metabolic","enrollment":150},{"nctId":"NCT00497120","phase":"NA","title":"A Combined Surgical and Medical Approach in Mild Sleep Apnea","status":"UNKNOWN","sponsor":"University Hospital, Antwerp","startDate":"","conditions":"Sleep Apnea","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL20"},"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Diamox. Drug and placebo are prepared in similar capsules."],"phase":"marketed","status":"active","brandName":"Placebo-acetazolamide","genericName":"Placebo-acetazolamide","companyName":"Shahid Beheshti University of Medical Sciences","companyId":"shahid-beheshti-university-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acetazolamide inhibits carbonic anhydrase to reduce aqueous humor production and intraocular pressure, while the placebo component serves as a control in clinical evaluation. Used for Glaucoma and ocular hypertension.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:16:48.730535+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}